At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 61 enrolled
Drug / intervention
XPF-001 +1 moredrug
Likely dose
XPF-001 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Safety, PK, & Efficacy of a Single Oral Dose of XPF-001 in the Treatment of Pain Related to Third Molar/Wisdom Tooth Extraction.
In Brief
A Phase 2 clinical trial evaluating XPF-001 and placebo for Dental Pain. Completed, enrolled 61 participants across 1 site.
Detailed Summary
The purpose of this trial is to determine if XPF-001 is effective for the treatment of pain following third-molar/wisdom tooth extraction.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDental Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 2009
Enrollment StartSep 2009
Primary CompletionNov 2009
Study CompletionDec 2009
TodayJul 2026
First PostedAug 7, 2009
Enrollment StartSep 1, 2009
Primary CompletionNov 1, 2009
Study CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.9 years ago
Interventions
XPF-001drug
Single oral administration of 500 mg XPF-001 capsules (5 x 100 mg capsules)
placebodrug
Single oral administration of 5 x 100 mg Placebo capsules.